EQUILLIUM INC (EQ) Fundamental Analysis & Valuation
NASDAQ:EQ • US29446K1060
Current stock price
2.15 USD
-0.17 (-7.33%)
At close:
2.1322 USD
-0.02 (-0.83%)
After Hours:
This EQ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. EQ Profitability Analysis
1.1 Basic Checks
- In the past year EQ has reported negative net income.
- In the past year EQ has reported a negative cash flow from operations.
- EQ had negative earnings in each of the past 5 years.
- EQ had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- EQ's Return On Assets of -70.76% is on the low side compared to the rest of the industry. EQ is outperformed by 62.93% of its industry peers.
- Looking at the Return On Equity, with a value of -78.92%, EQ is in line with its industry, outperforming 51.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.76% | ||
| ROE | -78.92% | ||
| ROIC | N/A |
ROA(3y)-45.84%
ROA(5y)-43.62%
ROE(3y)-98.95%
ROE(5y)-79.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- EQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. EQ Health Analysis
2.1 Basic Checks
- EQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for EQ has been increased compared to 1 year ago.
- Compared to 5 years ago, EQ has more shares outstanding
- EQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- EQ has an Altman-Z score of 12.26. This indicates that EQ is financially healthy and has little risk of bankruptcy at the moment.
- EQ's Altman-Z score of 12.26 is amongst the best of the industry. EQ outperforms 84.56% of its industry peers.
- There is no outstanding debt for EQ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 12.26 |
ROIC/WACCN/A
WACC8.87%
2.3 Liquidity
- EQ has a Current Ratio of 10.85. This indicates that EQ is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 10.85, EQ belongs to the best of the industry, outperforming 83.98% of the companies in the same industry.
- A Quick Ratio of 10.85 indicates that EQ has no problem at all paying its short term obligations.
- The Quick ratio of EQ (10.85) is better than 83.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.85 | ||
| Quick Ratio | 10.85 |
3. EQ Growth Analysis
3.1 Past
- EQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -342.86%.
- Looking at the last year, EQ shows a very negative growth in Revenue. The Revenue has decreased by -90.43% in the last year.
EPS 1Y (TTM)-342.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-90.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
3.2 Future
- EQ is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.08% yearly.
- Based on estimates for the next years, EQ will show a very negative growth in Revenue. The Revenue will decrease by -14.87% on average per year.
EPS Next Y-101.52%
EPS Next 2Y-11.98%
EPS Next 3Y-7.83%
EPS Next 5Y-6.08%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
3.3 Evolution
4. EQ Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for EQ. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EQ. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- EQ's earnings are expected to decrease with -7.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.98%
EPS Next 3Y-7.83%
5. EQ Dividend Analysis
5.1 Amount
- EQ does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EQ Fundamentals: All Metrics, Ratios and Statistics
2.15
-0.17 (-7.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners58.11%
Inst Owner Change24.74%
Ins Owners14.05%
Ins Owner Change-2.19%
Market Cap130.91M
Revenue(TTM)4.39M
Net Income(TTM)-24.42M
Analysts85.45
Price Target2.55 (18.6%)
Short Float %4.33%
Short Ratio3.74
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.93%
Min EPS beat(2)16.03%
Max EPS beat(2)59.83%
EPS beat(4)4
Avg EPS beat(4)39.05%
Min EPS beat(4)16.03%
Max EPS beat(4)59.83%
EPS beat(8)8
Avg EPS beat(8)58.68%
EPS beat(12)12
Avg EPS beat(12)84.03%
EPS beat(16)13
Avg EPS beat(16)61.88%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-30%
EPS NQ rev (3m)51.85%
EPS NY rev (1m)-4.65%
EPS NY rev (3m)39.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 29.81 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.23 | ||
| P/tB | 4.23 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.62
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.07
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.76% | ||
| ROE | -78.92% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-45.84%
ROA(5y)-43.62%
ROE(3y)-98.95%
ROE(5y)-79.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 6.92% | ||
| Cap/Sales | 0.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 10.85 | ||
| Quick Ratio | 10.85 | ||
| Altman-Z | 12.26 |
F-Score3
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)111.69%
Cap/Depr(5y)164.16%
Cap/Sales(3y)0.71%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-342.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-101.52%
EPS Next 2Y-11.98%
EPS Next 3Y-7.83%
EPS Next 5Y-6.08%
Revenue 1Y (TTM)-90.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y-259.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-295.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-295%
OCF growth 3YN/A
OCF growth 5YN/A
EQUILLIUM INC / EQ Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for EQUILLIUM INC?
ChartMill assigns a fundamental rating of 2 / 10 to EQ.
Can you provide the valuation status for EQUILLIUM INC?
ChartMill assigns a valuation rating of 0 / 10 to EQUILLIUM INC (EQ). This can be considered as Overvalued.
What is the profitability of EQ stock?
EQUILLIUM INC (EQ) has a profitability rating of 0 / 10.
What is the earnings growth outlook for EQUILLIUM INC?
The Earnings per Share (EPS) of EQUILLIUM INC (EQ) is expected to decline by -101.52% in the next year.